# An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

> **NCT01511393** · — · ENROLLING_BY_INVITATION · sponsor: **Novo Nordisk A/S** · enrollment: 6750 (estimated)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2
- Medullary Thyroid Carcinoma
- Weight Management

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT01511393
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2012-01
- **Primary completion:** 2039-12
- **Final completion:** 2039-12
- **Target enrollment:** 6750 (ESTIMATED)
- **Last updated:** 2023-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511393, "An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01511393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*